Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Centre Oscar Lambret
Tanta University
Institute of Oncology Ljubljana
University of California, San Diego
Next Biomedical Co., Ltd.
Cardiovascular and Interventional Radiological Society of Europe
Tongji University
Mayo Clinic
Lund University Hospital
Stanford University
Shanghai Zhongshan Hospital
Guangxi Medical University
University Hospital, Tours
Istanbul Medipol University Hospital
Memorial Sloan Kettering Cancer Center
Coherus Oncology, Inc.
University of Southern California
UNC Lineberger Comprehensive Cancer Center
MacroGenics
Shenzhen Third People's Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Icahn School of Medicine at Mount Sinai
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
The First Affiliated Hospital of Xiamen University
University Hospital Plymouth NHS Trust
Sir Run Run Shaw Hospital, Qingchun Campus, Zhejiang University School of Medicine,
Thomas Jefferson University
Novita Pharmaceuticals, Inc.
University of Texas Southwestern Medical Center
Federation Francophone de Cancerologie Digestive
Bayer
Thomas Jefferson University
San Camillo Hospital, Rome
Peking University First Hospital
Tvardi Therapeutics, Incorporated
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Boston Scientific Corporation
Intensity Therapeutics, Inc.
Alliance for Clinical Trials in Oncology
Sirtex Medical
Viome
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
ABK Biomedical
Bristol-Myers Squibb
GenVivo, Inc.